Literature DB >> 3169757

Podophyllotoxin 0.5% v podophyllin 20% to treat penile warts.

A Edwards1, A Atma-Ram, R N Thin.   

Abstract

The increasing incidence of genital warts has led to more public awareness of this infection and its possible sequelae. Currently available treatment remains unsatisfactory, and there is pressure to develop effective and convenient alternatives. Podophyllotoxin is standardised and stable, whereas podophyllin has a variable composition. In an open comparison of self applied podophyllotoxin 0.5% versus podophyllin 20% applied by a doctor to treat external penile warts, podophyllotoxin was more effective and gave quicker resolution than podophyllin. Side effects were similar for both preparations, and few patients experienced complications severe enough to stop treatment. Podophyllotoxin can therefore be used safely and effectively for home treatment monitored at an outpatient clinic and provides a useful alternative to treatment with podophyllin at overburdened genitourinary medicine clinics.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3169757      PMCID: PMC1194230          DOI: 10.1136/sti.64.4.263

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  8 in total

1.  Diagnosis and etiology of nongonococcal urethritis.

Authors:  S L Swartz; S J Kraus; K L Herrmann; M D Stargel; W J Brown; S D Allen
Journal:  J Infect Dis       Date:  1978-10       Impact factor: 5.226

Review 2.  Podophyllum toxicity: a report of a fatal case and a review of the literature.

Authors:  D E Cassidy; J Drewry; J P Fanning
Journal:  J Toxicol Clin Toxicol       Date:  1982-03

3.  Comparison of econazole and isoconazole as single dose treatment for vaginal candidosis.

Authors:  C S Bradbeer; R N Thin
Journal:  Genitourin Med       Date:  1985-12

4.  Systemic complications of local podophyllin therapy.

Authors:  G P Stoehr; A L Peterson; W J Taylor
Journal:  Ann Intern Med       Date:  1978-09       Impact factor: 25.391

5.  Scissor excision of anogenital warts.

Authors:  J M Gollock; K Slatford; J M Hunter
Journal:  Br J Vener Dis       Date:  1982-12

6.  Outpatient treatment of perianal warts by scissor excision.

Authors:  A McMillan; G R Scott
Journal:  Genitourin Med       Date:  1987-04

7.  Infrared coagulation in the treatment of condyloma acuminata in the female genital tract.

Authors:  Z Bekassy; L Weström
Journal:  Sex Transm Dis       Date:  1987 Oct-Dec       Impact factor: 2.830

8.  Latent papillomavirus and recurring genital warts.

Authors:  A Ferenczy; M Mitao; N Nagai; S J Silverstein; C P Crum
Journal:  N Engl J Med       Date:  1985-09-26       Impact factor: 91.245

  8 in total
  16 in total

1.  Editorial on management of anal warts is misleading.

Authors:  L A Riddell; A Edwards
Journal:  BMJ       Date:  2001-02-24

Review 2.  Podophyllin office therapy against condyloma should be abandoned.

Authors:  G von Krogh; E Longstaff
Journal:  Sex Transm Infect       Date:  2001-12       Impact factor: 3.519

3.  Genital warts: a comprehensive review.

Authors:  Valerie R Yanofsky; Rita V Patel; Gary Goldenberg
Journal:  J Clin Aesthet Dermatol       Date:  2012-06

4.  Podophyllin 0.5% or 2.0% v podophyllotoxin 0.5% for the self treatment of penile warts: a double blind randomised study.

Authors:  D J White; C Billingham; S Chapman; S Drake; D Jayaweera; S Jones; A Opaneye; C Temple
Journal:  Genitourin Med       Date:  1997-06

5.  A single-blind study of podophyllotoxin cream 0.5% and podophyllotoxin solution 0.5% in male patients with genital warts.

Authors:  C S Petersen; T Agner; V Ottevanger; J Larsen; L Ravnborg
Journal:  Genitourin Med       Date:  1995-12

Review 6.  Warts (genital).

Authors:  Henry W Buck
Journal:  BMJ Clin Evid       Date:  2010-08-13

7.  Viral Venereal Diseases of the Skin.

Authors:  Theodora K Karagounis; Miriam K Pomeranz
Journal:  Am J Clin Dermatol       Date:  2021-05-18       Impact factor: 7.403

Review 8.  Warts (genital).

Authors:  Henry W Buck
Journal:  BMJ Clin Evid       Date:  2007-08-01

9.  Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.

Authors:  Richard Gilson; Diarmuid Nugent; Kate Bennett; Caroline J Doré; Macey L Murray; Jade Meadows; Lewis J Haddow; Charles Lacey; Frank Sandmann; Mark Jit; Kate Soldan; Michelle Tetlow; Emilia Caverly; Mayura Nathan; Andrew J Copas
Journal:  Health Technol Assess       Date:  2020-09       Impact factor: 4.014

Review 10.  Advancements in Pharmacotherapy for Noncancerous Manifestations of HPV.

Authors:  Ramya Kollipara; Erfon Ekhlassi; Christopher Downing; Jacqueline Guidry; Michael Lee; Stephen K Tyring
Journal:  J Clin Med       Date:  2015-04-24       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.